This deal falls under Teva’s wider strategy to prioritise strategic, financially diligent deals around de-risked, differentiated, late-stage assets.

The integration aims to ensure planning is based on real-world clinical developments, uniting internal and external insights.

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60 mill ...

Spread the loveThe pharmaceutical industry is currently a dynamic and rapidly evolving sector, marked by significant advancements and challenges. As we progress through 2026, several notable trends ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

In part 1 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains the difference between a new excipient and a novel excipient and what goes into developing a ...

Real-time biofluorescent particle counting enables immediate interventions versus delayed culture results, improving batch protection and strengthening proactive contamination control strategies.

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced today it has reached a remarkable milestone by winning five categories ...

Beijing Danatlas Pharmaceutical Technology Co. Ltd. has described heterocyclic derivatives acting as DNA polymerase θ (POLθ, POLQ) inhibitors reported to be useful for the treatment of cancer.

Henan Medinno Pharmaceutical Technology Co. Ltd. has synthesized TGF-β receptor type-1 (TGFBR1; ALK5; SKR4; TβR-I) inhibitors reported to be useful for the treatment of cancer, aging, arteriosclerosis ...